Share these talks and lectures with your colleagues
Invite colleaguesWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- A bit about the presenter
- Specific challenges relative to…
- Marketing in life sciences
- Regulated advertising frameworks
- Other considerations
- Marketing healthcare services
- Marketing services and products
- Issues with marketing healthcare services
- Issue #1 - Intangibility (Oncology)
- Issue #1 - Intangibility (Physiotherapy)
- Issue #2 - Fluctuating demand /perishability
- Issue #2 - Solutions
- Issue #3 - Uniformity of service
- Issue #3 - Solutions
- Marketing healthcare digital products
- Value of digital products
- Marketing strategies - Digital products
- Marketing strategies - Trials
- Issues with healthcare digital products
- Issues around data and security
- Questions?
This material is restricted to subscribers.
Topics Covered
- Marketing in life sciences
- Services versus products
- Examples and solutions
- Digital products and services
- Main issues of marketing healthcare services
Talk Citation
Denault, J. (2020, April 30). Marketing in life sciences: healthcare services and healthcare digital products [Video file]. In The Business & Management Collection, Henry Stewart Talks. Retrieved November 8, 2024, from https://doi.org/10.69645/XZXR9585.Export Citation (RIS)
Publication History
Extended-form Case Study
Marketing in life sciences: healthcare services and healthcare digital products
Published on April 30, 2020
17 min
Other Talks in the Series: Marketing Strategy
Transcript
Please wait while the transcript is being prepared...
0:00
This chapter, discussion on unique perspective.
It will be a little bit more about what makes
marketing life sciences a little bit more unique than marketing in other sectors.
So it's very interesting for people who have experience in marketing,
but a little less about marketing in life sciences.
You can modulate your approach or you can see where there are some differences to do.
0:23
As always, I will be giving the course today.
Jean-Francois Denault, I am independent consultant in this sector for over 15 years,
specialized in life sciences.
Working with companies in medical devices, nutraceuticals,
biotech, pharma, healthcare from large pharma to small start-ups.
0:42
The three specific challenges we'll be looking at today is marketing life sciences,
the challenges of marketing healthcare services versus health care product,
and the third challenge we'll be looking at
is marketing strategy for digital products and services.
1:02
Marketing in life sciences.
What we know.
Well, one of the things that is very unique to
life sciences is that products and services are very complex.
It's going to be be a lot more complex for the end-user to understand,
so there is a lot of work and trust to be gained,
and there is a lot of reliance on third-party sources
and even secondary sources such as your friends,
your family, your doctor,
your nurses, people you trust.
Products in life sciences have a direct impact on end-users.
They have very long development cycles,
they have very long approval cycles,
and you have to have a concern that when you're doing your products,
how they will change your end-users health.
You're not just making a pair of socks,
you're picking a pair of socks for people with diabetes,
and hence you are changing their general welfare.
You are also marketing to a population that does not always have
the knowledge to evaluate and distinguish claims.
So your message and how you deliver it must balance
the information and educational content without being patronizing and insulting.
You have to find a way to simplify the information enough for them to be able
to catch it without being oversimplified and downright insulting.
Hide